PFNLive
- Stocks Head Lower, Market on Track for Weekly Loss
- Valeant Said to Be Near to Acquiring Bausch & Lomb
- Novo Obesity Drug Could Launch in U.S. End 2014
- Intuitive Wins Trial, Defeats Negligent Training Claims
- Futures Trim Declines after Durable Goods
- Aveo Shares Shellacked After Astellas Drops EU Game Plan on Kidney Cancer
- Merck Halts Development of Parkinson’s Drug on Lack of Benefit
- Wall Street Sags, but Ends off Session Lows
- Elan Board Unanimously Rejects $6.4 Billion Takeover Offer
- Wall Street Mostly Dips, but off Lows with Help from HP
- Royalty Cuts Acceptance Bar for Elan Bid to 50 Pct
- Stock Slump Continues on Wall Street
- Merck Insomnia Drug Safe Only in Lower Doses
- Shares in NZ's F&P Healthcare Jump After Record Profit
- Wall St. to Drop at Open on Stimulus Plan Worry, China Data
- Boston Scientific’s Lotus Aortic Valve Has Promise in Study
- BioMarin Gains on Prospects for Experimental Cancer Drug
- Wall Street Falters in Volatile Session on Fed Worries
- Gilead Steals a March for Hepatitis C Drug Application
- Boehringer Ingelheim Handed FDA Warning Letter
